Detalhe da pesquisa
1.
The Cellular Characterization of SARS-CoV-2 Spike Protein in Virus-Infected Cells Using the Receptor Binding Domain Binding Specific Human Monoclonal Antibodies.
J Virol
; 96(13): e0045522, 2022 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-35727030
2.
Induction of protective immunity against influenza A/Jiangxi-Donghu/346/2013 (H10N8) in mice.
J Gen Virol
; 98(2): 155-165, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27983474
3.
The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody.
PLoS One
; 16(6): e0253487, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34161386
4.
Complete protection against lethal challenge of novel H7N9 virus with heterologous inactivated H7 vaccine in mice.
Vaccine
; 32(42): 5375-8, 2014 Sep 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-25130540